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Cardiac Remodeling in Obesity
Time for a New Paradigm*
Sheldon E. Litwin, MD
Salt Lake City, UtahApproximately 70% of people in the U.S. are
overweight or obese, nearly twice as many as 30
years ago. Much of the conventional wisdom about
obesity and the heart came from small studies
performed 30 to 40 years ago (1,2). These studies
suggested that obesity produced chronic volume
overload due to high cardiac output. This led to
See page 266
eccentric hypertrophy and the eventual develop-
ment of congestive heart failure (2). The term
cardiomyopathy of obesity was coined by Alexander
(3) in 1985, and the concept that adiposity has an
independent causal role in producing cardiac dys-
function is now widely embraced (4). Longer dura-
tion of severe obesity has been suggested as the
main factor predisposing to cardiac dysfunction (5).
Case reports of severely obese patients with heart
failure that resolved after significant weight loss
seem to support this notion (2).
In contrast to the paradigm described, several recent
studies (6–9) reported that most obese subjects have
concentric left ventricular (LV) remodeling or hyper-
trophy. Increased wall thickness or mass relative to
cavity size is usually thought of as a sequela of chronic
pressure overload rather than volume overload. Inter-
estingly, concentric LV geometry has been observed in
obese patients, even in the absence of documented
hypertension (7,9). Although hypertension does not
seem to be necessary for LV hypertrophy in obesity,
the combination of a higher body mass index (BMI)
and hypertension synergistically acts to further in-
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
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and the Department of Veterans Affairs Hospital, Salt Lake City, Utah.crease LV mass (6). Sleep apnea also contributes to
LV hypertrophy in obese subjects (6). Additionally, it
has been proposed that elevated levels of insulin,
insulin-like growth factor 1, or various adipocytokines
(e.g., leptin) produce direct trophic effects on the heart
(10,11).Whatever the mechanism(s), there is substan-
tial new evidence that most obese people have con-
centric LV geometry, not dilated, thin-walled hearts.
A distinct cardiomyopathy of obesity is called
into question by the findings of several recent
studies. First, the mild concentric LV hypertrophy
in the majority of obese subjects enrolled in popu-
lation studies does not fit well with the conventional
clinical definition of a cardiomyopathy. Second,
even though obese subjects have subclinical LV
systolic dysfunction as assessed by mid-wall frac-
tional shortening or tissue Doppler or strain imag-
ing, obese individuals consistently have normal or
increased LV ejection fractions (6,8,9,12). More-
over, there is no association between the ejection
fraction and the severity of obesity (i.e., LV func-
tion is not worse in the most obese subjects). There
are no longitudinal studies showing progression of
LV dysfunction over time in obese humans. In fact,
mild concentric LV hypertrophy and subtle con-
tractile abnormalities have been reported in obese
children, adolescents, and adults (6,8,12–14). If
obesity commonly causes a cardiomyopathy, one
would predict a more consistent pattern of worsen-
ing LV function with older age and severity of
obesity. The majority of recent reports show, at
most, mild diastolic abnormalities in obese individ-
uals (8,9,15,16). Mitral inflow has been normal or
has demonstrated a slow relaxation pattern, findings
usually associated with normal LV filling pressures.
Tissue Doppler imaging and strain imaging have
revealed only slight reductions of early diastolic
myocardial relengthening velocities (8). No pro-
spective studies have reported significant numbers
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276f obese patients with pseudonormal or restrictive
V filling patterns, findings that are expected if
hese patients had significant diastolic dysfunction.
The aforementioned studies may be criticized
ecause they used echocardiography to assess LV
tructure and function. Imaging windows become
ore limited as body weight increases. Thus, echo-
ardiography may be less accurate in the more obese
opulations. One of the larger studies of echocar-
iography in obese subjects to date included 851
everely obese subjects (6), but most studies have
ncluded fewer than 150 subjects. It may be argued
hat the relatively small sample sizes might have
roduced selection bias. These concerns can be
argely laid to rest by an impressive new study.
In this issue of iJACC, Turkbey et al. (17) report
esults of cardiac magnetic resonance (CMR) in
,098 subjects aged 45 to 84 years without apparent
ardiac disease who were enrolled in the Multi-
thnic Study of Atherosclerosis (MESA). In the
ESA population, 29% were overweight, 41%
ere obese,  40% had hypertension, and 10% had
iabetes. These demographics are reflective of the
eneral population in the U.S. The main findings of
he study were that both LV mass and end-diastolic
olume were positively associated with measures of
besity. This remained true for both sexes after
djustment for other risk factors. The LV mass-to-
olume ratio was positively associated with all
easures of obesity including BMI, waist circum-
erence, waist-to-hip ratio, and estimated fat mass.
he obese subjects in this study had a high ratio of
V mass to volume, indicating concentric remod-
ling or hypertrophy. Ejection fractions were nor-
al or increased (mean men, 67%; women, 71%)
nd showed no significant association with obesity.
The investigators participating in the MESA study
re to be commended for the monumental effort
nvolved in performing and analyzing cardiac CMR
cans in over 6,000 subjects. This well-designed study
sed a gold-standard imaging technique in a very large
opulation free of referral bias. The results resound-
ngly confirm the main findings from most of the
ecent studies on this topic: LV mass increases out of
roportion to cavity size in obese individuals and the
egree of concentric remodeling is positively related to
MI and other measures of adiposity. The findings
hallenge the view that obesity causes a state of
hronic volume overload that is predominantly asso-
iated with eccentric LV remodeling.
The data from this study do not support the
xistence of a cardiomyopathy of obesity, at least if
ardiac enlargement or reduced ejection fraction are Eonsidered as usual components of a cardiomyopa-
hy. Furthermore, 2 findings in this study challenge
he hypothesis that longer duration of obesity leads
o LV dysfunction. First, the subjects in this study
ere older (mean age 61 years) than those in
revious studies. In most cases, severe obesity re-
uires decades to develop. Even the most obese
ndividuals in the MESA study had changes in
ardiac structure and function that were strikingly
imilar to those reported in much younger popula-
ions with lesser degrees of obesity. Second, the
bsence of any trend toward reduced ejection frac-
ion, even at the highest BMIs, leads to the con-
lusion that chronicity of the obese condition does
ot necessarily lead to overt contractile dysfunction.
n contrast, it is increasingly clear that obesity is
ssociated with both the premature onset of coro-
ary atherosclerosis (18) and more rapid atheroscle-
osis progression (19). Thus, comorbid conditions,
uch as ischemic heart disease, likely explain part of
he predilection of obese patients to the develop-
ent of heart failure (20).
CMR findings in the current study are very similar
o those of the most recent studies using echocardi-
graphy. Thus, echocardiography is generally a suit-
ble technique for assessment of cardiac structure and
unction in obesity. This is important because echo-
ardiography is ubiquitous, safe, fast, and less costly
han CMR. Furthermore, CMR may be difficult to
se in severely obese subjects due to the confining size
f the bore on most modern CMR units. The ability
o obtain similar data with echocardiography and
MR is a testimony to the steady advances that have
een achieved in cardiac ultrasound imaging technol-
gy since its inception over 50 years ago.
In summary, it is time to consider a new paradigm
egarding the structural and functional impacts of
besity on the heart. Obesity, even when severe and
ong-standing, is most often associated with concen-
ric LV remodeling, normal LV ejection fraction, and
ubclinical abnormalities of systolic and diastolic func-
ion. There is little evidence that these abnormalities
re progressive. With no end in sight to the obesity
pidemic, rigorous investigations such as the study by
urkbey et al. (17) will be increasingly important. It is
mperative that we gain further understanding of how
besity affects the heart and modulates the cardiovas-
ular responses to lifestyle changes, surgical interven-
ions, and pharmacotherapies.
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